Evidence map›Paper›PMID 21609430›Full record

ArticleJournal of neuroinflammation2011

Sesamin ameliorates oxidative stress and mortality in kainic acid-induced status epilepticus by inhibition of MAPK and COX-2 activation.

Peiyuan F Hsieh, Chien-Wei Hou, Pei-Wun Yao, Szu-Pei Wu, Yu-Fen Peng, Mei-Lin Shen, Ching-Huei Lin, Ya-Yun Chao, Ming-Hong Chang, Kee-Ching Jeng

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 94 citations in OpenAlex.

  1. Review
  2. Anti-Inflammatory Effect of Medicinal FungusFood technology and biotechnology · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Effects of sesame (Food science & nutrition · 2023
    Review
  7. Article
  8. Review
  9. Review
  10. An aqueous extract ofHeliyon · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Health benefits of sesamin on cardiovascular disease and its associated risk factors.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2020
    Review
  16. Was Hawan Designed to Fight Anxiety-Scientific Evidences?Journal of religion and health · 2020
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Peiyuan F HsiehDivision of Neurology, Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan. pfhsieh@vghtc.gov.tw
Chien-Wei Hou
Pei-Wun Yao
Szu-Pei Wu
Yu-Fen Peng
Mei-Lin Shen
Ching-Huei Lin
Ya-Yun Chao
Ming-Hong Chang
Kee-Ching Jeng
Taichung Veterans General Hospital · TWYuanpei University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKainic acid (KA)-induced status epilepticus (SE) was involved with release of free radicals. Sesamin is a well-known antioxidant from sesame seeds and it scavenges free radicals in several brain injury models. However the neuroprotective mechanism of sesamin to KA-induced seizure has not been studied.

methodsRodents (male FVB mice and Sprague-Dawley rats) were fed with sesamin extract (90% of sesamin and 10% sesamolin), 15 mg/kg or 30 mg/kg, for 3 days before KA subcutaneous injection. The effect of sesamin on KA-induced cell injury was also investigated on several cellular pathways including neuronal plasticity (RhoA), neurodegeneration (Caspase-3), and inflammation (COX-2) in PC12 cells and microglial BV-2 cells.

resultsTreatment with sesamin extract (30 mg/kg) significantly increased plasma α-tocopherol level 50% and 55.8% from rats without and with KA treatment, respectively. It also decreased malondialdehyde (MDA) from 145% to 117% (p=0.017) and preserved superoxide dismutase from 55% of the vehicle control mice to 81% of sesamin-treated mice, respectively to the normal levels (p=0.013). The treatment significantly decreased the mortality from 22% to 0% in rats. Sesamin was effective to protect PC12 cells and BV-2 cells from KA-injury in a dose-dependent manner. It decreased the release of Ca2+, reactive oxygen species, and MDA from PC12 cells. Western blot analysis revealed that sesamin significantly reduced ERK1/2, p38 mitogen-activated protein kinases, Caspase-3, and COX-2 expression in both cells and RhoA expression in BV-2 cells. Furthermore, Sesamin was able to reduce PGE2 production from both cells under KA-stimulation.

conclusionsTaken together, it suggests that sesamin could protect KA-induced brain injury through anti-inflammatory and partially antioxidative mechanisms.

Indexed as

AnimalsAntioxidantsBehavior, AnimalCell SurvivalCyclooxygenase 2Cyclooxygenase 2 InhibitorsDioxolesEnzyme ActivationKainic AcidLignansLipid PeroxidationMaleMiceMitogen-Activated Protein KinasesNeuroprotective AgentsOxidative StressAntioxidantsCyclooxygenase 2Cyclooxygenase 2 InhibitorsDioxolesKainic AcidLignansMitogen-Activated Protein KinasesNeuroprotective AgentsReactive Oxygen SpeciesrhoA GTP-Binding Proteinsesamin

Identifiers

PMID21609430
PMCPMC3129306
OpenAlexW2141585732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.